Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
Potentially, H4R signaling could provide an alternative target for IBD treatment differing from most current IBD therapies that target adaptive immune pathways
N Ballatori, SM Krance, S Notenboom, S Shi, K Tieu, CL Hammond
You may be used to taking herbal supplements like moringa for its high antioxidant levels or its reputation for supporting metabolic health
This activity is supported by Sanofi
A meta-analysis conducted by Mabilleau et al